Each week, Health Affairs Editor-in-Chief Alan Weil brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry.
A Health Podyssey goes beyond the pages of the health policy journal Health Affairs to tell stories behind the research and share policy implications. Learn how academics and economists frame their research questions and journey to the intersection of health, health care, and policy. Health policy nerds rejoice! This podcast is for you.
Leemore Dafny on Hospital Prices, Markets, and Antitrust Regulations
Health Affairs Editor-in-Chief Alan Weil interviews Leemore Dafny from Harvard Business School and Harvard Kennedy School on hospital prices, market concentration and why market measurements are lacking.
Pushing Against the QALY Criticism in Drug Pricing
Health Affairs Editor-in-Chief Alan Weil interviews Leah Rand, a postdoctoral fellow at Harvard Medical School and Brigham and Women’s Hospital, on the pros and cons of the Quality Adjusted Life Year (QALY) measurement in health policy.
Julian Harris on the Connection Between Unmet Social Needs and Health Care Costs
In our first special Excursion episode, Health Affairs Editor-in-Chief Alan Weil interviews Julian Harris, CEO of ConcertoCare. The two discuss social determinants of health, the connection between unmet social needs and health care costs, how COVID-19 affected health equity, why the Program of All-inclusive Care for the Elderly (PACE) is special and more.
Scott Howell on the Very Large Costs of Drug Utilization Management
Health Affairs Editor-in-Chief Alan Weil interviews Scott Howell, chief strategy officer of US pharmaceuticals at Novartis Pharmaceuticals on drug utilization management and the tension between drug manufacturers and pharmaceutical benefit designs.
LIVE with Chiquita Brooks-LaSure, Centers for Medicare and Medicaid Services Administrator
Listen to Health Affairs Editor-in-Chief Alan Weil interview the Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure at a live Health Affairs speaker event from August 12, 2021.
James Robinson On The Drug Market, Innovation, Biosimilars, and What The French Get Right
Health Affairs Editor-in-Chief Alan Weil interviews James Robinson from the University of California, Berkeley School of Public Health on drug innovation, biosimilars, and market competition in the United States and beyond.